Evaluation of miR18a-5p, miR22-3p, miR24-3p, miR106b-5p, miR107, miR125b-5p and miR155a-5p levels in child and adolescent patients with attention deficit hyperactivity disorder
( Psychiatry and Clinical Psychopharmacology 2014; 24: S87-S88)
( Psychiatry and Clinical Psychopharmacology 2014; 24: S87-S88)